Search - tctmd.com

Displaying 1 - 20 of 45

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2025

Caitlin E. Cox

April 30, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2025

Caitlin E. Cox

April 01, 2025

News Conference News TCT 2024

Percutaneous Mechanical Aspiration Promising for Right-Heart Infective Endocarditis

Caitlin E. Cox

November 08, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2024

Caitlin E. Cox

September 03, 2024

News Daily News

Top Structural Heart News of 2022

L.A. McKeown

January 06, 2023

News Opinion Editor's Corner

The Biggest News of 2022: TCTMD’s Top 10

Shelley Wood

December 30, 2022

Presentation TCT 2022

TCT 333: Effect of stroke on readmissions and cardiovascularoutcomes in patients with Mitraclip.

Presenter: Nirav Patel

September 19, 2022

Presentation TCT 2022

TCT 332: Clinical outcome of transcatheter aortic valve replacement with TriGUARD 3™ cerebral embolic protection device

Presenter: Sayonara Daal

September 19, 2022

Presentation TCT 2022

TCT 331: Predictors of Valvular and Perivalvular Thrombosis and Relations of Neurological Outcomes after TAVR: ADAPT-TAVR Substudy

Presenter: Yeonwoo Choi

September 19, 2022

Presentation TCT 2022

TCT 329: Cerebral Embolic Protection Devices For Prevention Of Post-Procedural Ischemic Stroke With Transcatheter Aortic Valve Replacement: A SYSTEMATIC REVIEW AND META-ANALYSIS

Presenter: Tanesh Ayyalu

September 18, 2022

Presentation TCT 2022

TCT 328: Low-dose or Standard-dose Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombus and Cerebral Thromboembolism after Transcatheter Aortic Valve Replacement (TAVR): Subgroup Analysis of the Randomized ADAPT-TAVR Trial

Presenter: Mijin Kim

September 18, 2022

Presentation TCT 2022

TCT 327: Clinical and Radiographic Measures of Stroke-Related Outcomes with Cerebral Embolic Protection Devices During TAVR: A Meta-analysis.

Presenter: Arpanjeet Kaur

September 18, 2022

Presentation TCT 2022

TCT 324: Cerebral Embolic Protection Devices and Outcomes of Transcatheter Aortic Valve Replacement: Insight from National Readmission Database 2017-2019.

Presenter: Ahmed Altibi

September 17, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

Innovation Gone Wild - Next-Generation TRIGUARD Cerebral Embolic Protection During TAVR: Technology Review and Status of Ongoing Clinical Trials

Presentation TCT 2019

Next-Generation TRIGUARD Cerebral Embolic Protection During TAVR: Technology Review and Status of Ongoing Clinical Trials

Presenter: Tamim Nazif

September 27, 2019

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

Presentation TVT 2016

The Case for and Against Cerebral Embolic Protection During TAVR

Presenter: Susheel Kodali

June 16, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2016

Shelley Wood

May 31, 2016

News Daily News

卒中率下降使人质疑是否有必要在 TAVR 中置入血栓预防设备

Michael O'Riordan

March 14, 2016

News Daily News

Bajan los Índices de ACV y Aumentan las Dudas sobre los Dispositivos de Protección Embólica en las Intervenciones TAVR

Michael O'Riordan

March 14, 2016

Advertisement

TCTMD’s Top 10 Most Popular Stories for April 2025

TCTMD’s Top 10 Most Popular Stories for March 2025

Percutaneous Mechanical Aspiration Promising for Right-Heart Infective Endocarditis

TCTMD’s Top 10 Most Popular Stories for August 2024

Top Structural Heart News of 2022

The Biggest News of 2022: TCTMD’s Top 10

TCT 333: Effect of stroke on readmissions and cardiovascularoutcomes in patients with Mitraclip.

TCT 332: Clinical outcome of transcatheter aortic valve replacement with TriGUARD 3™ cerebral embolic protection device

TCT 331: Predictors of Valvular and Perivalvular Thrombosis and Relations of Neurological Outcomes after TAVR: ADAPT-TAVR Substudy

TCT 329: Cerebral Embolic Protection Devices For Prevention Of Post-Procedural Ischemic Stroke With Transcatheter Aortic Valve Replacement: A SYSTEMATIC REVIEW AND META-ANALYSIS

TCT 328: Low-dose or Standard-dose Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombus and Cerebral Thromboembolism after Transcatheter Aortic Valve Replacement (TAVR): Subgroup Analysis of the Randomized ADAPT-TAVR Trial

TCT 327: Clinical and Radiographic Measures of Stroke-Related Outcomes with Cerebral Embolic Protection Devices During TAVR: A Meta-analysis.

TCT 324: Cerebral Embolic Protection Devices and Outcomes of Transcatheter Aortic Valve Replacement: Insight from National Readmission Database 2017-2019.

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Next-Generation TRIGUARD Cerebral Embolic Protection During TAVR: Technology Review and Status of Ongoing Clinical Trials

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

The Case for and Against Cerebral Embolic Protection During TAVR

TCTMD’s Top 10 Most Popular Stories for May 2016

卒中率下降使人质疑是否有必要在 TAVR 中置入血栓预防设备

Bajan los Índices de ACV y Aumentan las Dudas sobre los Dispositivos de Protección Embólica en las Intervenciones TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content